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INTRODUCTION

METHODS

• 24-month data were collected between October 2016 and March 2017, based on when
hospitals completed 2-years of program participation

• In 2014, the American College of Cardiology (ACC) launched the Patient Navigator Program to
assist 35 acute care hospitals in the implementation of transition-care strategies aimed at
improving in-hospital and post-discharge outcomes for AMI and HF
• The program required hospitals to develop AMI and HF improvement goals
based on facility-specific baseline measure results

• At each hospital, the site coordinator completed a survey in 2017.
• Specific Outcomes — Change at Year 2, Compared to Baseline in:

• The program facilitators at the ACC provided Patient Navigator Program support structures,
processes and services to enhance hospital success
• Of hospitals, we previously reported variation in care delivery and in 30-day re-hospitalization
rates; however, it is unknown if use of and perceived value of site-specific and ACC Patient
Navigator Program-facilitated services were associated with program outcomes (30-day
rehospitalization and in-hospital risk adjusted AMI death) and AMI and HF process metrics.
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Purpose: To prospectively examine 2-year outcome and process metrics based on hospital site
perceptions of the use of and value of their own site-specific and also, ACC Patient Navigator
Program-facilitated services.
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METHODS
Design
• The ACC Patient Navigator Program engaged 35 acute care hospitals in setting goals and
implementing strategies aimed at improving structures, processes, and outcomes of
transition-care for a 2-year period
• Outcome and process metrics were prospectively collected 24 months after
program implementation
• After 2 years, sites prospectively completed surveys on their implementation of site-specific and
ACC Patient Navigator Program-facilitated structure, system and processes
Intervention Elements (and survey response options)
• Hospitals were encouraged to initiate site-specific and ACC-facilitated services to promote
transitional-care quality improvements:
• Number of hospital structure, system and process changes (categorized as low [0-2],
moderate [3-5], and high [6-8])
• Number of site-specific technologies (categorized as low [0-2], moderate [3-5], and
high [6-9])
• Value of using an ACC Patient Navigator Program-facilitated list-serv that promoted site
coordinator communication (Likert-like scale from 1-5)
• Value of ACC Patient Navigator Program-facilitated educational calls and webinars
(Likert-like scale from 1-5)
• Value of ACC Patient Navigator Program-facilitated quality-focused site visits
(Likert-like scale from 1-5)
• Value of ACC Patient Navigator Program-generated data reports
(Likert-like scale from 1-5)
Outcomes and Data Collection:
• All outcome and process performance metrics had standard inclusion and exclusion criteria
• Some data were derived from the Chest Pain - MI Registry
• Sites provided data for HF measures via medical record review
• Each hospital site had designated personnel responsible for submitting data to a Chest Pain - MI
Registry web-based data collection tool.
• Each hospital provided a minimum of 60 patient-cases per quarter, 30 AMI and 30 HF.
• Baseline data were collected between July 2013 and August 2014, based on when hospitals
entered the program
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RESULTS

continued

Number of site-initiated technologies
• The number of site-initiated technologies was not associated with any outcome or process
metric changes at program end, compared to baseline.
Value of using a list-serv to communicate with other program sites
• Value of the list-serv was not associated with any outcome or process metric changes at
program end, compared to baseline.
Value of program-led educational calls and webinars
• Sites that rated calls/ webinars as high value were more likely to improve AMI-HF self-care
treatment education documentation; Figure 2.
Value of Community Calls and Webinars

Risk -adjusted in hospital death, AMI
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patient referral, AMI

100%
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•

All tests were 2-sided, and p< 0.05 was used to determine statistical significance.

•

All analyses were performed using SAS version 9.4 (SAS Institute Inc.; Cary, NC).

RESULTS
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p=0.014
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• Were more likely to have an improvement in 30-day unadjusted AMI and HF
rehospitalization rates at 2 year assessment, compared to baseline;

100%

p=0.021

• Because there were not concurrent control hospitals, secular trends could account for some or
all of the findings.
• Our findings reflect performance at only 35 hospitals that voluntarily participated in the Chest
Pain-MI Registry and received funding to participate.
• Findings should be interpreted cautiously since other hospitals might not be able to
implement or maintain a similar program.

Value of ACC-Facilitated Patient Navigator Program Site Visits
p=0.007

p=0.035

CONCLUSIONS
• In a geographically diverse cohort of 35 hospitals treating patients with AMI and HF,
• Sites that implemented more structure, system and process changes advocated by the
Patient Navigator Program were more likely to have a decrease in 30-day unadjusted AMI
and HF re-hospitalization at 2 year assessment, compared to baseline.
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• Sites that placed high value on ACC Patient Navigator Program-facilitated community calls
and webinars, site visits and data reports were more likely to have a decrease in 30-day
unadjusted AMI and HF re-hospitalization at 2 year assessment, compared to baseline.
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• The Patient Navigator Program was not a randomized clinical trial

Value of quality-related site visits
• Sites that rated ACC Patient Navigator Program-facilitated visits as high value:
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• Relationships are confounded by measured and unmeasured variables.
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• Reported data represent observational process and outcome metrics and site-coordinator
perceived survey responses
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Limitations
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# Changes in Structures/Systems/Processes
to Implement the Patient Navigator Program

Value of ACC Patient Navigator Program Data Reports

0%

• Were less likely to improve LVSD evaluation; Figure 3.

Number of hospital structure, system and process changes
• Sites were more likely to have an improvement in 30-day HF re-hospitalization at 2 year
assessment, compared to baseline if they implemented more changes; Figure 1.

• They were more likely to have an improvement in 30-day unadjusted HF re-hospitalization
at 2 year assessment, compared to baseline; Figure 4.
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Statistical Analysis
• To examine the associations between the level of use of each site and ACC-facilitated process or
system and the change in 30-day unadjusted AMI and HF rehospitalization, in-hospital risk
adjusted AMI death and 14 AMI-HF process metrics from baseline to 2-years, the
Cochran-Armitage test was conducted.

• They were more likely to have an improvement in 30-day unadjusted AMI re-hospitalization
at 2 year assessment, compared to baseline,
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Value of ACC-facilitated data reports
• When sites rated reports as high value:
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ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; LVSD,
Left-ventricular systolic dysfunction; NSTEMI/STEMI, non-ST/ST elevated myocardial infarction
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RESULTS

continued

• Acute myocardial infarction (AMI) and heart failure (HF) are prevalent conditions with
substantial in-hospital and post-discharge morbidity and mortality
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• Site technology and ACC Patient Navigator Program-facilitated list-serv activities by site
coordinators were not associated with any outcome or process performance metrics
• Many performance metrics of interest, especially most process metrics did not change from
baseline based on the site-initiated or ACC Patient Navigator Program-facilitated services.
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